Based on the provided forecast data, Spain's pharmaceutical industry export market share is projected to gradually decline from 2024 to 2028, decreasing from a value of 1.89 in 2024 to 1.86 in 2028. In 2023, the actual market share value was 1.90. The year-on-year variation shows a consistent decrease of approximately 0.53% annually. Over the five-year forecast period from 2024 to 2028, the compound annual growth rate (CAGR) is estimated to be -0.26%, reflecting a modest but steady downward trend.
Future trends to watch for include potential impacts from global economic shifts, advances in pharmaceutical technology, changes in regulatory policies, and the emergence of competitive markets. Additionally, shifts in demand for specific drugs and the outcomes of trade negotiations could further influence Spain's export market share in the pharmaceutical industry.
